| 2015 American College of Rheumatology guideline for the treatment of rheumatoid arthritis JA Singh, KG Saag, SL Bridges Jr, EA Akl, RR Bannuru, MC Sullivan, ... Arthritis & rheumatology 68 (1), 1-26, 2016 | 3894 | 2016 |
| EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update JS Smolen, R Landewé, J Bijlsma, G Burmester, K Chatzidionysiou, ... Annals of the rheumatic diseases 76 (6), 960-977, 2017 | 3265 | 2017 |
| EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update JS Smolen, RBM Landewé, JWJ Bijlsma, GR Burmester, M Dougados, ... Annals of the rheumatic diseases 79 (6), 685-699, 2020 | 2863 | 2020 |
| 2012 update of the 2008 American College of Rheumatology recommendations for the use of disease‐modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid … JA Singh, DE Furst, A Bharat, JR Curtis, AF Kavanaugh, JM Kremer, ... Arthritis care & research 64 (5), 625-639, 2012 | 2262 | 2012 |
| The recent prevalence of osteoporosis and low bone mass in the United States based on bone mineral density at the femoral neck or lumbar spine NC Wright, AC Looker, KG Saag, JR Curtis, ES Delzell, S Randall, ... Journal of bone and mineral research 29 (11), 2520-2526, 2014 | 2076 | 2014 |
| American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease‐modifying antirheumatic drugs in rheumatoid arthritis KG Saag, GG Teng, NM Patkar, J Anuntiyo, C Finney, JR Curtis, ... Arthritis Care & Research: Official Journal of the American College of …, 2008 | 2063 | 2008 |
| Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis KG Saag, R Emkey, TJ Schnitzer, JP Brown, F Hawkins, S Goemaere, ... New England Journal of Medicine 339 (5), 292-299, 1998 | 1617 | 1998 |
| 2015 gout classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative T Neogi, TLTA Jansen, N Dalbeth, J Fransen, HR Schumacher, ... Arthritis & rheumatology 67 (10), 2557-2568, 2015 | 1611 | 2015 |
| Romosozumab or alendronate for fracture prevention in women with osteoporosis KG Saag, J Petersen, ML Brandi, AC Karaplis, M Lorentzon, T Thomas, ... New England Journal of Medicine 377 (15), 1417-1427, 2017 | 1380 | 2017 |
| Vitamin D intake is inversely associated with rheumatoid arthritis: results from the Iowa Women's Health Study LA Merlino, J Curtis, TR Mikuls, JR Cerhan, LA Criswell, KG Saag Arthritis & Rheumatism: Official Journal of the American College of …, 2004 | 1240 | 2004 |
| 2011 American College of Rheumatology recommendations for the treatment of juvenile idiopathic arthritis: initiation and safety monitoring of therapeutic agents for the … T Beukelman, NM Patkar, KG Saag, S Tolleson‐Rinehart, RQ Cron, ... Arthritis care & research 63 (4), 465-482, 2011 | 1185 | 2011 |
| Teriparatide or alendronate in glucocorticoid-induced osteoporosis KG Saag, E Shane, S Boonen, F Marín, DW Donley, KA Taylor, GP Dalsky, ... New England Journal of Medicine 357 (20), 2028-2039, 2007 | 1109 | 2007 |
| American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid‐induced osteoporosis JM Grossman, R Gordon, VK Ranganath, C Deal, L Caplan, W Chen, ... Arthritis care & research 62 (11), 1515-1526, 2010 | 990 | 2010 |
| Rheumatoid arthritis disease activity measures: American College of Rheumatology recommendations for use in clinical practice J Anderson, L Caplan, J Yazdany, ML Robbins, T Neogi, K Michaud, ... Arthritis care & research 64 (5), 640-647, 2012 | 985 | 2012 |
| Cardiovascular safety of febuxostat or allopurinol in patients with gout WB White, KG Saag, MA Becker, JS Borer, PB Gorelick, A Whelton, ... New England Journal of Medicine 378 (13), 1200-1210, 2018 | 949 | 2018 |
| The clinician’s guide to prevention and treatment of osteoporosis MS LeBoff, SL Greenspan, KL Insogna, EM Lewiecki, KG Saag, AJ Singer, ... Osteoporosis international 33 (10), 2049-2102, 2022 | 834 | 2022 |
| Low dose long-term corticosteroid therapy in rheumatoid arthritis: an analysis of serious adverse events KG Saag, R Koehnke, JR Caldwell, R Brasington, LF Burmeister, ... The American journal of medicine 96 (2), 115-123, 1994 | 757 | 1994 |
| The clinical diagnosis of osteoporosis: a position statement from the National Bone Health Alliance Working Group ES Siris, R Adler, J Bilezikian, M Bolognese, B Dawson-Hughes, ... Osteoporosis international 25, 1439-1443, 2014 | 749 | 2014 |
| Two‐year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids: a randomized, double‐blind, placebo‐controlled extension trial JD Adachi, KG Saag, PD Delmas, UA Liberman, RD Emkey, E Seeman, ... Arthritis & Rheumatism: Official Journal of the American College of …, 2001 | 728 | 2001 |
| Gout epidemiology: results from the UK general practice research database, 1990–1999 TR Mikuls, JT Farrar, WB Bilker, S Fernandes, HR Schumacher Jr, ... Annals of the rheumatic diseases 64 (2), 267-272, 2005 | 701 | 2005 |
